Back to results
US 5,206,240 AGranted
Nitrogen-containing spirocycles
AssigneeMerck & Co., Inc.
InventorsJohn J. Baldwin, Jason M. Elliott, David A. Claremon, Gerald S. Ponticello, David C. Remy, Harold G. Selnick
Life of this patent
Estimating the term…
Abstract
Spirocycles of general structural formula: ##STR1## are Class III antiarrhythmic agents.
Claims4
A compound of structural formula:
- ##STR372## or a pharmaceutically acceptable salt thereof, wherein Ar.sup.1 is benzo;
- the ring system comprising X, Y and Z is a 5-, 6- or 7-membered ring system wherein X is CHOH or CO;
- Y is CH, a bond or (CR.sub.4 R.sub.5).sub.m ;
- and Z is --0--;
- wherein:
- R.sup.4 and R.sup.5 are independently
- a) hydrogen, or
- b) C.sub.1-6 alkyl;
- M is
- 1) --H,
- 2) --OH,
- 3) --O(C.sub.1-6 alkyl),
- 4) --CN,
- 5) --NHSO.sub.2 C.sub.1-6 alkyl,
- 6) --COOH,
- 7) --COOC.sub.1-6 alkyl,
- 8) --CONR.sup.12 R.sup.13, wherein R.sup.12 and R.sup.13 are independently
- a) hydrogen,
- b) C.sub.1-6 alkyl, or
- c) R.sup.12 and R.sup.13 taken together with the nitrogen atom to which they are attached represent a 5 or 6 membered saturated heterocyclic ring which may contain an additional heteroatom selected from N, S(O).sub.n or O, wherein n is 0-2, selected from the group consisting of pyrrolidine, morpholine, piperidine, piperazine or N-methylpiperazine,
- 9) --NR.sup.12 R.sup.13,
- 10) halo,
- 11) C.sub.5-8 cycloalkane,
- 12) C.sub.5-8 cycloalkene, or
- 13) ##STR373## wherein s is 1-3 and the R.sup.3 groups may be the same or different;
- R is --(CR.sup.4 R.sup.5).sub.m --Q--(CR.sup.4 R.sup.5).sub.q --, wherein R.sup.4 and R.sup.5 are as defined above, m and q are O, Q is a bond;
- R.sup.1, R.sup.2, and R.sup.3 are independently selected from:
- 1) hydrogen,
- 2) C.sub.1-6 alkyl, either unsubstituted or substituted with
- a) --NR.sup.4 R.sup.5, wherein R.sup.4 and R.sup.5 are as defined above,
- b) --N(R.sup.5)COC.sub.1-6 alkyl,
- c) --NHSO.sub.2 (C.sub.1-6 alkyl),
- d) --CONR.sup.12 R.sup.13, wherein R.sup.12 and R.sup.13 are as defined above,
- e) --CO(C.sub.1-6 alkyl),
- f) --OH,
- g) --O(C.sub.1-6 alkyl),
- h) --O(C.sub.1-6 alkyl)--O--(C.sub.1-3 alkyl),
- i) --S(O).sub.n (C.sub.1-6 alkyl),
- j) imidazole,
- k) 2-imidazolidinone,
- l) 2-pyrrolidinone,
- m) --NH--C(NHR.sup.5).dbd.N--CN, or
- n) --NH--C(SR.sup.5).dbd.N--CN,
- 3) --OH,
- 4) C.sub.1-3 alkoxy, either unsubstituted or substituted with C.sub.1-3 alkoxy,
- 5) --N(R.sup.5)SO.sub.2 (C.sub.1-6 alkyl),
- 6) --N(R.sup.5)SO.sub.2 (CH.sub.2).sub.g CO.sub.2 H,
- 7) --N(R.sup.5)SO.sub.2 (CH.sub.2).sub.g CO.sub.2 C.sub.1-6 alkyl,
- 8) --NO.sub.2,
- 9) --N(R.sup.5)COC.sub.1-6 alkyl,
- 10) --N(R.sup.5)SO.sub.2 --C.sub.6 H.sub.4 --R.sup.4,
- 11) --N(R.sup.5)CO--C.sub.6 H.sub.4 --R.sup.4,
- 12) --NR.sup.4 R.sup.5,
- 13) halo,
- 14) --CO--C.sub.1-6 alkyl,
- 15) --CONR.sup.12 R.sup.13,
- 16) --CN,
- 17) --CO.sub.2 R.sup.5,
- 18) --C(R.sup.5).dbd.N--OR.sup.9,
- 19) benzoyl, either unsubstituted or substituted with C.sub.1-6 alkyl, C.sub.1-6 alkoxy, halo, or hydroxy,
- 20) --N(R.sup.5)COO(C.sub.1-6 alkyl),
- 21) --N(R.sup.5)COO--phenyl either unsubstituted or substituted with C.sub.1-6 alkyl, C.sub.1-6 alkoxy, hydroxy or halo,
- 22) --N(R.sup.5)CONR.sup.4 R.sup.5,
- 23) --S(O).sub.n C.sub.1-6 alkyl,
- 24) --S(O).sub.n --C.sub.6 H.sub.4 --R.sup.4,
- 25) --CF.sub.3,
- 26) phenyl, either unsubstituted or substituted with C.sub.1-6 alkyl, C.sub.1-6 alkoxy, halo or hydroxy,
- 27) imidazolyl,
- 28) --SO.sub.2 NR.sup.12 R.sup.13,
- 29) --N[S(O).sub.2 C.sub.1-6 alkyl][(CH.sub.2).sub.p CN], wherein p is 2-5,
- 30) --N(R.sup.5)--C(NR.sup.4 R.sup.5).dbd.N--CN, or
- 31) --N(R.sup.5)--C(SR.sup.5).dbd.N--CN;
- B is piperidine;
- and
- Ar.sup.2 is benzene or naphthalene;
- with the proviso that if Ar.sup.1 is benzo, and R.sup.1 and R.sup.2 are hydrogen, hydroxyalkyl or alkoxy, then M is other than unsubstituted phenyl or hydrogen.
73 more elements
Dependencies are inferred from the claim text.